Milestone Pharmaceuticals (MIST) Other Accumulated Expenses (2018 - 2026)
Milestone Pharmaceuticals (MIST) posted Other Accumulated Expenses of $43000.0 for Q1 2026, little changed on a QoQ basis from $43000.0 in Q4 2025, and down 88.65% year-over-year from $379000.0 in Q1 2025.
Milestone Pharmaceuticals (MIST) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
Milestone Pharmaceuticals' Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $43000.0 for Q1 2026.
- Quarterly Other Accumulated Expenses fell 88.65% year-over-year to $43000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43000.0 (down 88.65% YoY) and the FY2025 annual result came in at $43000.0, down 91.04% from the prior year.
- Other Accumulated Expenses was $43000.0 for Q1 2026 at Milestone Pharmaceuticals, roughly flat from $43000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $1.3 million in Q3 2023 and bottomed at $43000.0 in Q4 2025.
- A 5-year average of $472941.2 and a median of $392000.0 in 2022 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses soared 212.93% — and 2025, when it plunged 91.04%.
- Milestone Pharmaceuticals' Other Accumulated Expenses stood at $255000.0 in 2022, then slipped by 1.18% to $252000.0 in 2023, then soared by 90.48% to $480000.0 in 2024, then plunged by 91.04% to $43000.0 in 2025, then changed by 0.0% to $43000.0 in 2026.
- Business Quant data shows MIST's Other Accumulated Expenses at $43000.0 in Q1 2026, $43000.0 in Q4 2025, and $518000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,000.00 |
| Dec 31, 2025 | 43,000.00 |
| Sep 30, 2025 | 518,000.00 |
| Jun 30, 2025 | 243,000.00 |
| Mar 31, 2025 | 379,000.00 |
| Dec 31, 2024 | 480,000.00 |
| Sep 30, 2024 | 376,000.00 |
| Jun 30, 2024 | 309,000.00 |
| Mar 31, 2024 | 466,000.00 |
| Dec 31, 2023 | 252,000.00 |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 637,000.00 |
| Mar 31, 2023 | 546,000.00 |
| Dec 31, 2022 | 255,000.00 |
| Sep 30, 2022 | 760,000.00 |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | 392,000.00 |
| Dec 31, 2021 | 437,000.00 |
| Sep 30, 2021 | 339,000.00 |
| Jun 30, 2021 | 348,000.00 |